WO2001080936A1 - Stent - Google Patents
Stent Download PDFInfo
- Publication number
- WO2001080936A1 WO2001080936A1 PCT/JP2001/003368 JP0103368W WO0180936A1 WO 2001080936 A1 WO2001080936 A1 WO 2001080936A1 JP 0103368 W JP0103368 W JP 0103368W WO 0180936 A1 WO0180936 A1 WO 0180936A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- cell
- tubular body
- cells
- axial direction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
Definitions
- the present invention relates to an improvement of a stent used for improving a stenosis generated in a living body such as a blood vessel.
- a stent is a tubular medical device that is placed in a blood vessel or other in-vivo lumen when the stenosis or occlusion is obstructed or obstructed, in order to expand the stenotic portion and secure a necessary lumen area.
- the stent is inserted into the body with a small diameter and expanded at a stenosis or the like to increase the diameter to expand and hold the lumen.
- FIGS. 11 and 12 Conventionally used stents are, for example, typically as shown in FIGS. 11 and 12, but these have the following problems. Note that, in FIGS. 1.1 and 12, (A) shows a plan view before expansion of the stent, and (B) shows a plan view after expansion.
- the cells 206 constituting the linear unit 204 have three straight portions 207 connected in parallel, and the cells 206
- the stent 2441 shown in FIG. 12 is composed of a cell 246 constituting a linear unit 244, and a substantially-shaped strut (striatum) 247 is a connecting portion 245.
- the structure is connected by For this reason, there is an advantage that the radiation supporting force is strong and the substantially strut-shaped strut 247 does not warp outward when expanding or passing through a bent portion of a blood vessel.
- the conventional stent has a problem that it does not have both the flexibility and the balance of the radiation supporting force.
- a stent 1 (1A, IB) that forms a substantially tubular body with an annular unit composed of a plurality of cells and is radially expandable from the inside of the tubular body, wherein the plurality of cells 6 (6A , 6B) are connected up and down, and a plurality of these are arranged so as to surround the central axis C1 of the stent forming the tubular body, thereby forming the annular unit 4 (4A, 4B).
- (1A, IB) is extended in the axial direction, and the extension is performed by connecting at least one portion of the annular units 4 (4A, 4B) by a connecting portion 5 (5A5B), And,
- the cell 6 (6A, 6B) has at least one or more bent portions 12 (12As 12B), and at least when the diameter ⁇ of the tubular body is expanded to 2.5 mm, Stent 1 (1 ⁇ , 1 ⁇ ) ⁇ characterized in that the angle 6> after expansion of 12 (12 As 12B) is formed to be 30 D or more.
- the connecting portion 5 (5A, 5B) is composed of at least two or more bent portions 8 and a substantially straight portion 7 continuous with the bent portions 8, and adjacent different annular units. 4 (4 As 4 B), the cell 6 (6A, 6B) and the stent 1 according to (1) or (2), which are connected to an end of the cell. 1 B) o (4) The cell 6 (6 A) connects at least one or more substantially straight portions 11 (11A) and curved portions 13 (13A) via the bent portions 12 (12A).
- the stent according to any one of (1) to (3), wherein the stent is formed by:
- the cell 6B has a substantially linear portion 11B having an acute angle X with respect to an axial centerline C2 of each stent 1B, and an axial direction of the stent 1B via the bent portion 12B.
- the stent according to any one of [1] to [3], wherein the stent is formed by connecting to a substantially straight portion 13B disposed substantially horizontally with respect to the center line C2 of the stent.
- the connecting portion 5 (5A, 5B) is formed by connecting a bent portion 8 to both sides of the substantially linear portion 7 at the center, and the end of the bent portion 8 is connected to the connecting portion 9 (9A, 9B).
- the connecting portion 9 (9A, 9B).
- ) Are connected to the ends of the cells 6 (6 As 6B) constituting the adjacent different annular units 4 (4A, 4B), respectively.
- Stent 1 (1A, 1 B) o
- the cell 6 (6A, 6B) is characterized by being vertically asymmetric with respect to the center line C2 when partitioned vertically by a center line C2 in the stent axial direction. 1)
- the stent 1 (1A, 1B) according to any one of [6].
- the connecting portion 5 (5A, 5B) is arranged with at least one space in the radial direction of the stent 1 (1A, IB).
- FIG. 1 is a plan view of the stent of the present invention
- FIG. 2 is an enlarged view of FIG.
- FIG. 3 is an enlarged view showing a state of the stent of the present invention after expansion
- FIG. 4 is a conceptual view of a strut constituting a cell
- FIG. 5 is a diagram showing a state in which the diameter of the stent is reduced at the time of delivery to a blood vessel.
- FIG. 6 is a plan view showing another embodiment of the stent of the present invention
- FIG. 7 is a partially enlarged plan view of FIG. 6
- FIG. 9 is a plan view showing an example of another embodiment of the stent of FIG. 9, and
- FIG. 9 is a partially enlarged plan view of FIG.
- FIG. 10 is an enlarged view of a reference example of the stent of the present invention
- FIGS. 11 and 12 are plan views of a conventional stent, respectively.
- 1, 1A and IB are stents, 4, 4A and 4B are annular units, 5, 5A and 5B are connection parts, 6, 6A and 6B are cells, 7 is a substantially linear part, 8 is a bent part, 9 is a connection part, 11, 11A, 1 IB 13B is a substantially straight part, 12, 12A, 12B is a bent part, 13, 13A is a curved part, 14, 14A is a small bent part, and 15 is a substantially straight part.
- Reference numerals 17 and 17 denote substantially rectangular cells, 18 denotes a substantially S-shaped connecting portion, and 19 denotes a component in the stents A and B.
- FIG. 1 is a plan view of the stent of the present invention
- FIG. 2 is an enlarged view of FIG. 1
- FIG. 3 is an enlarged view showing a state of the stent of the present invention after expansion
- FIG. It is a conceptual diagram of a strut.
- the stent 1 forms a substantially tubular body by a tubular unit 4 composed of a plurality of cells 6, and is expandable in a radial direction from the inside of the tubular body.
- the cells 6 are connected vertically and a plurality of these cells are arranged so as to surround the central axis C1 of the stent 1 forming the tubular body, thereby forming the annular unit 4.
- the stent 1 forming the body is extended in the axial direction, and the extension is performed by connecting at least one portion of the annular units 4 by a connecting portion 5.
- the cell 6 means one constituent unit of a pattern constituting the surface of the stent 1, and as shown in FIG. 2, at least one or more bent portions 12, specifically, It has a bent portion 12 having an acute angle X, and includes all forms configured by connecting a substantially straight portion 11 and a bent portion 13 via the bent portion 12. Further, when each of the cells 6 is vertically divided by a center line C2 in the axial direction of the stent, the cells 6 are formed vertically asymmetrically with respect to the center line C2. When expanded to 5 mm, the angle 0 of the bent portion 12 after expansion is formed to be 30 ° or more, as shown in FIG.
- the angle 0 after the expansion of the bent portion 12 is, as shown in FIG. Means the angle formed between the point 0 and the substantially straight part 11 and the substantially straight part 15 near the point 0 side of the curved part 13.
- the cell 6 is formed by connecting a substantially straight portion 11 and a curved portion 13 via a bent portion 12, and the curved portion 13 has a small bent portion 14 having an obtuse angle Y. It is preferable to form by forming more than two places.
- the curved portion 13 (hereinafter, also referred to as a substantially S-shaped portion) having the substantially straight portion 11, the bent portion 12, and the small bent portion 14 constituting the cell 6 forms a stent (or a tubular body) after expansion of the stent.
- the angle after expansion of the bent portion 12 is at least 30 ° or more).
- the number of cells 6 arranged in the radial direction is preferably 4 or more. That is, when the diameter of the stent is 3.Omm or more, it is desirable to arrange 6 or more, preferably 6 to 12 pieces.
- the angle 6> after the expansion of the bent portion 12 is at least 30 ° or more, preferably 45 ° to 140 °, more preferably 45 ° to 120 °. It is desirable to design between.
- the shape of the struts of the cells 6 is determined in the axial direction of the stent of each cell. As shown in FIG. 4 (a), it is preferable to form asymmetrically with respect to the center line C2, as shown in FIG. 4 (b), rather than symmetrically as shown in FIG. 4 (a). This means that the asymmetrical formation increases the relative length of the entire strut (for example, when comparing Fig. 4 (a) and (b), it is always 2a + c + d), This is because the expandability of the stent itself can be increased, and the effect of suppressing foreshortening can be increased.
- the connecting portion 5 of the cells 6 and 6 in the stent 1 has at least two or more bent portions, and has bent portions 8 and 8 on both sides of the substantially linear portion 7 at the center.
- the end portions of the bent portions 8 are connected to the end portions of the cells 6, 6 constituting different (adjacent) annular units 4, 4 via the connection portions 9, 9. Has been continued.
- the connecting portion 5 is connected to both ends of the cells 6, 6 asymmetrically.
- the overall length including the substantially straight portion 7 and the bent portions 8 and 8 is 1 mm or more and the flexibility is improved.
- the diameter of the stent may be slightly reduced on the balloon catheter
- the upper and lower connecting portions 5 interfere with each other, and conversely, the flexibility is impaired. Therefore, it is desirable that the length of the entire connecting portion is 1 mm or more, preferably 1 mm to 2 mm.
- the ratio of the axial length 6L of the stent of the cell 6 to the axial length 5L of the stent of the connecting portion 5 is 6L.
- 5L is preferably formed from 50 to 100, and more preferably from 50 to 90 for convenience of design. As a result, it is possible to suppress the flare phenomenon at the time of delivery once the stent is expanded, and to impart flexibility to the stent itself.
- each cell 6 is arranged asymmetrically with respect to the axial center line C 2 of the stent via the connecting portion 5, but in the axial direction of the stent, They are arranged in the same direction and at the same height. That is, the cells 6 in the axial direction of the stent are arranged so as to overlap each other if they are moved in the axial direction of the stent from the nth row to the (n + 1) th row. Also, cells 6 in the same row (same tubular unit) are arranged in the same direction in the radial direction of the stent so as to overlap each other when slid up or down in the same row.
- the substantially straight portion 11 of each cell is substantially horizontal (substantially parallel) with respect to the center line C2, however, as long as the angle 0 after expansion of the bent portion 12 does not become less than 30 °. It may be at an angle and at an angle.
- the connecting portions 5 are also arranged asymmetrically in the axial direction of the stent via the cells 6, but are arranged in the same direction and at the same height in the axial direction of the stent. That is, the connection portions 5 in the axial direction of the stent are arranged so as to overlap with each other when viewed from the nth row to the (n + 1) th row in the axial direction of the stent.
- the rows of connecting parts 5 are also arranged in the same direction in the radial direction of the stent so as to overlap with each other when viewed from the top or the bottom of the row.
- the width of the struts constituting the cells 6 is preferably formed to be larger than the width of the struts constituting the connecting portions 5, and the cells 6 and the connecting portions 5 in the axial direction of the stent are preferably formed.
- the heights are preferably shifted so that they are not the same height but different from each other.
- the stent 1 has a ratio of the angle 0 after expansion of the bent portion 12 to the axial length 6 L of the stent of the cell 6 and the axial length 5 L of the connection portion of the stent of the cell 6.
- the ratio By defining the ratio, the configuration of the connecting portion 5 and the cell 6, the radial arrangement of the stent of the connecting portion 5 and the cell 6, and the axial arrangement (pattern) as described above, as shown in FIG.
- the diameter of the stent 1 is reduced at the time of delivery to a blood vessel, the cell 6 and the connecting portion 5 do not overlap each other three-dimensionally in the radial direction of the stent. That is, as shown in FIG.
- FIGS. 6 and 8 are plan views showing examples of other embodiments of the stent of the present invention.
- FIGS. 7 and 9 are partial views of FIGS. 6 and 8, respectively. It is an enlarged plan view.
- the stent 1A shown in FIGS. 6 and 7 is basically the same as the stent 1 shown in FIG. 1, but differs only in the following points. That is, (a) each cell 6A has a substantially straight portion 11A having an acute angle X with respect to each axial centerline C2 of the stent 1A in the axial direction, and a curved portion 1A through the bent portion 12A. (In contrast, in the stent 1, each cell 6 is substantially horizontal (substantially parallel) with respect to the center line C2 in the axial direction of the stent 1. It is configured by connecting the arranged substantially straight portion 11 to the curved portion 13 via the bent portion 12.) Point, (b) The cell 6 A is connected to the stent 1 via the connecting portion 5 A.
- the axial cells 6A of the stent 1A are tentatively arranged in every other row from the nth row to the (n + 2) th row. When viewed in the axial direction, the only difference is that they are arranged so as to overlap each other.
- the other components and their definitions are substantially the same as those of the stent 1, and therefore, detailed description is omitted.
- each cell 6B is different from the stents 1 and 1A shown in FIGS. 1, 6 and 7;
- the substantially linear portion 11B having an acute angle X with respect to the axial centerline C2 of the stent 1B in the axial direction is substantially horizontal to the axial centerline C2 of the stent 1 via the bent portion 12B.
- the stents 1 and 1A have the cells 6 and 6A that are connected to the substantially linear portions 11 and 1B.
- 1A is connected to the curved portions 13 and 13A via the bent portion 12. The points and the like are different from the stents 1 and 1A only.
- each cell 6B is arranged symmetrically in the axial direction of the stent 1B via the connecting portion 5B and (c) the cell 6B in the axial direction of the stent 1B
- the stent 1B differs from the stent 1 in that it is arranged so as to overlap each other, but differs from the stent 1A. Substantially the same. Since the other components and their definitions are substantially the same as those of the stents 1 and 1A, detailed descriptions are omitted. Abbreviate.
- each of the cells 6, 6A and 6B constituting each annular unit 4, 4A and 4B is provided.
- the connecting portions 5, 5As 5B are arranged continuously without any gap in the radial direction of the stents 1, 1A, 1B, but may be arranged with at least one space in the radial direction. In this way, by arranging the connection parts every other space or every other or two spaces as appropriate, the entire stent 1, 1A, and IB becomes more flexible, and the delivery to branching blood vessels is improved. It is expected to be.
- the materials constituting the stents 1, 1A, and IB of the present invention may be known materials themselves, and are not particularly limited.
- stainless steel such as SUS316L, Ti—Ni alloy, and €! 11—
- shape memory alloys such as 11 alloys, 11 alloys, Cu-Zn alloys, Ni-A1 alloys, titanium, titanium alloys, tantalum, tantalum alloys, platinum, platinum alloys, tungsten, tungsten alloys, etc.
- it is formed by a laser processing method or the like.
- a stent formed of these metals is coated with a biocompatible polymer material such as polyurethane, polyvinylpyrrolidone, or polyvinyl alcohol, or a bioactive material such as heparin or perokinase by chemical bonding to the polymer material. It may be coated with a substance to which a substance is fixed, or a mixture of the polymer material and an antithrombotic agent such as argatroban, silas sol, or salvogrelate hydrochloride.
- a biocompatible polymer material such as polyurethane, polyvinylpyrrolidone, or polyvinyl alcohol
- a bioactive material such as heparin or perokinase by chemical bonding to the polymer material. It may be coated with a substance to which a substance is fixed, or a mixture of the polymer material and an antithrombotic agent such as argatroban, silas sol, or salvogrelate hydrochloride.
- stent A (B) composed of a component 19 composed of a substantially ⁇ -shaped cell 17 and a substantially S-shaped connecting part 18 shown in Fig. 10
- the difference in the radiation support force due to the difference in the angle after expansion was evaluated.
- stents A (number of arrangements 8) and stents B (number of arrangements 6) having different numbers of arrangements of the components 19 in the circumferential direction were manufactured as described below, and the radiant bearing capacity of each was evaluated and compared.
- Stent A Number of components 19 arranged 8
- Stent B Number of components 19 arranged 6 Strat width of cell 17 0.12 mm
- the stent 1 shown in Fig. 1 was manufactured, and the radiative bearing force was compared with the conventional stents 201 (Fig. 11) and 241 (Fig. 12), and the flexibility was compared with the stent 201. .
- Radiation bearing capacity was evaluated in the same manner as in Example 1, and flexibility was evaluated by a four-point bending method.
- Table 2 shows the measurement results of the radiative bearing force
- Table 3 shows the measurement results of the flexibility.
- the stent 1 of the present invention has a smaller change in outer diameter than either of the stents 201 and 241 and, as is clear from the results in Table 3, the stent 201 It was confirmed that the bending strength was smaller. As described above, it was confirmed that the stent 1 of the present invention was a stent having both high radiation supporting force and flexibility. Species example 3
- the stents 1, 1A, and IB of the present invention were confirmed to have much smaller foreshortening values than the conventional stents 201 and 241.
- the stent of the present invention can sufficiently secure both high flexibility and radiation supporting force, and can also enhance vasodilatory and suppress foreshortening and flare phenomenon. It can be suitably used as a stent for expanding the space and securing a necessary lumen region.
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20010921925 EP1277489B1 (en) | 2000-04-20 | 2001-04-19 | Stent |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-118939 | 2000-04-20 | ||
JP2000118939 | 2000-04-20 | ||
JP2000-236340 | 2000-08-04 | ||
JP2000236340A JP3654627B2 (ja) | 2000-04-20 | 2000-08-04 | ステント |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001080936A1 true WO2001080936A1 (en) | 2001-11-01 |
Family
ID=26590442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/003368 WO2001080936A1 (en) | 2000-04-20 | 2001-04-19 | Stent |
Country Status (4)
Country | Link |
---|---|
US (1) | US7179285B2 (ja) |
EP (1) | EP1277489B1 (ja) |
JP (1) | JP3654627B2 (ja) |
WO (1) | WO2001080936A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7794494B2 (en) | 2002-10-11 | 2010-09-14 | Boston Scientific Scimed, Inc. | Implantable medical devices |
US7976936B2 (en) | 2002-10-11 | 2011-07-12 | University Of Connecticut | Endoprostheses |
US8043361B2 (en) | 2004-12-10 | 2011-10-25 | Boston Scientific Scimed, Inc. | Implantable medical devices, and methods of delivering the same |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
DE60141231D1 (de) * | 2000-09-22 | 2010-03-18 | Boston Scient Scimed Inc | Intravaskulärer Stent |
US8070792B2 (en) | 2000-09-22 | 2011-12-06 | Boston Scientific Scimed, Inc. | Stent |
WO2002060521A1 (en) * | 2001-02-01 | 2002-08-08 | Kaneka Corporation | Stent |
JP3605388B2 (ja) | 2001-10-16 | 2004-12-22 | 川澄化学工業株式会社 | ステント |
US20040054398A1 (en) * | 2002-09-13 | 2004-03-18 | Cully Edward H. | Stent device with multiple helix construction |
US20040093056A1 (en) | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
DE10261822A1 (de) * | 2002-12-20 | 2004-07-01 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Helix-Steg-Verbindung |
US7521623B2 (en) | 2004-11-24 | 2009-04-21 | Apple Inc. | Music synchronization arrangement |
US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
US7604660B2 (en) | 2003-05-01 | 2009-10-20 | Merit Medical Systems, Inc. | Bifurcated medical appliance delivery apparatus and method |
EP1629861A4 (en) * | 2003-06-02 | 2011-05-11 | Nipro Corp | SOFT STENT WITH EXCELLENT BLOOD VESSEL TRACKING |
JP4844394B2 (ja) * | 2004-06-25 | 2011-12-28 | 日本ゼオン株式会社 | ステント |
US7867272B2 (en) * | 2004-10-26 | 2011-01-11 | Cordis Corporation | Stent having twist cancellation geometry |
JP2007117548A (ja) * | 2005-10-31 | 2007-05-17 | Japan Stent Technology Co Ltd | ステント |
US20070135894A1 (en) * | 2005-12-13 | 2007-06-14 | Robert Burgermeister | Polymeric stent having modified molecular structures in the flexible connections |
US20070135896A1 (en) * | 2005-12-13 | 2007-06-14 | Robert Burgermeister | Polymeric stent having modified molecular structures in the flexible connectors and the radial struts of the hoops |
US20070135892A1 (en) * | 2005-12-13 | 2007-06-14 | Robert Burgermeister | Polymeric stent having modified molecular structures in the flexible connectors and in the radial struts and the radial arcs of the hoops |
US8348991B2 (en) * | 2006-03-29 | 2013-01-08 | Boston Scientific Scimed, Inc. | Stent with overlap and high expansion |
US20080177371A1 (en) * | 2006-08-28 | 2008-07-24 | Cornova, Inc. | Implantable devices and methods of forming the same |
US7988720B2 (en) | 2006-09-12 | 2011-08-02 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US8974514B2 (en) | 2007-03-13 | 2015-03-10 | Abbott Cardiovascular Systems Inc. | Intravascular stent with integrated link and ring strut |
EP2201966A4 (en) | 2007-09-04 | 2013-06-26 | Japan Stent Technology Co Ltd | STENT FOR THE CONTROLLED RELEASE OF MEDICAMENTS |
WO2010101072A1 (ja) | 2009-03-02 | 2010-09-10 | 株式会社日本ステントテクノロジー | 薬剤溶出性ステント |
CN102497838A (zh) * | 2009-09-17 | 2012-06-13 | 株式会社日本斯滕特技术 | 支架 |
US8114149B2 (en) * | 2009-10-20 | 2012-02-14 | Svelte Medical Systems, Inc. | Hybrid stent with helical connectors |
WO2011132803A1 (ko) * | 2010-04-20 | 2011-10-27 | 주식회사 엠아이텍 | 개선된 구조를 가지는 혈관 확장용 스텐트 |
EP4173599A1 (en) | 2012-05-14 | 2023-05-03 | C. R. Bard, Inc. | Uniformly expandable stent |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
EP2967939A4 (en) * | 2013-03-14 | 2016-12-14 | Palmaz Scient Inc | MONOLITHIC MEDICAL DEVICE AND METHODS OF MAKING AND USING |
JP2016209128A (ja) * | 2015-04-30 | 2016-12-15 | 川澄化学工業株式会社 | ステント |
AU2018214780B2 (en) | 2017-02-01 | 2022-02-03 | Japan Medical Device Technology Co., Ltd. | Bioabsorbable stent |
CN107550611B (zh) * | 2017-10-18 | 2024-03-15 | 科塞尔医疗科技(苏州)有限公司 | 一种血管支架 |
CN109009590B (zh) * | 2018-08-24 | 2024-04-26 | 四川大学 | 生物梯形可降解支架 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996026689A1 (en) * | 1995-03-01 | 1996-09-06 | Scimed Life Systems, Inc. | Improved longitudinally flexible expandable stent |
DE29702671U1 (de) | 1997-02-17 | 1997-04-10 | Jomed Implantate Gmbh | Stent |
US5911754A (en) | 1998-07-24 | 1999-06-15 | Uni-Cath Inc. | Flexible stent with effective strut and connector patterns |
WO1999038457A1 (en) * | 1998-02-03 | 1999-08-05 | Jang G David | Tubular stent consisting of horizontal expansion struts and contralaterally attached diagonal-connectors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922021A (en) * | 1996-04-26 | 1999-07-13 | Jang; G. David | Intravascular stent |
IT1292295B1 (it) * | 1997-04-29 | 1999-01-29 | Sorin Biomedica Cardio Spa | Stent per angioplastica |
DE29708879U1 (de) * | 1997-05-20 | 1997-07-31 | Jomed Implantate Gmbh | Koronarer Stent |
US6261319B1 (en) * | 1998-07-08 | 2001-07-17 | Scimed Life Systems, Inc. | Stent |
-
2000
- 2000-08-04 JP JP2000236340A patent/JP3654627B2/ja not_active Expired - Fee Related
-
2001
- 2001-04-19 EP EP20010921925 patent/EP1277489B1/en not_active Expired - Lifetime
- 2001-04-19 US US10/257,407 patent/US7179285B2/en not_active Expired - Fee Related
- 2001-04-19 WO PCT/JP2001/003368 patent/WO2001080936A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996026689A1 (en) * | 1995-03-01 | 1996-09-06 | Scimed Life Systems, Inc. | Improved longitudinally flexible expandable stent |
DE29702671U1 (de) | 1997-02-17 | 1997-04-10 | Jomed Implantate Gmbh | Stent |
WO1999038457A1 (en) * | 1998-02-03 | 1999-08-05 | Jang G David | Tubular stent consisting of horizontal expansion struts and contralaterally attached diagonal-connectors |
US5911754A (en) | 1998-07-24 | 1999-06-15 | Uni-Cath Inc. | Flexible stent with effective strut and connector patterns |
Non-Patent Citations (1)
Title |
---|
See also references of EP1277489A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7794494B2 (en) | 2002-10-11 | 2010-09-14 | Boston Scientific Scimed, Inc. | Implantable medical devices |
US7976936B2 (en) | 2002-10-11 | 2011-07-12 | University Of Connecticut | Endoprostheses |
US8784465B2 (en) | 2002-10-11 | 2014-07-22 | Boston Scientific Scimed, Inc. | Implantable medical devices |
US9115245B2 (en) | 2002-10-11 | 2015-08-25 | Boston Scientific Scimed, Inc. | Implantable medical devices |
US8043361B2 (en) | 2004-12-10 | 2011-10-25 | Boston Scientific Scimed, Inc. | Implantable medical devices, and methods of delivering the same |
Also Published As
Publication number | Publication date |
---|---|
EP1277489B1 (en) | 2014-01-08 |
JP3654627B2 (ja) | 2005-06-02 |
EP1277489A4 (en) | 2007-03-14 |
EP1277489A1 (en) | 2003-01-22 |
US7179285B2 (en) | 2007-02-20 |
US20030158596A1 (en) | 2003-08-21 |
JP2002000739A (ja) | 2002-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001080936A1 (en) | Stent | |
WO2003039642A1 (fr) | Endoprothese vasculaire | |
US9504587B2 (en) | Intravascular stent | |
US8882826B2 (en) | Intravascular stent | |
JP6220386B2 (ja) | 均一に拡張可能なステント | |
EP1874221B1 (en) | Endoprosthesis | |
KR20070020481A (ko) | 콘투어드 브릿징 부재를 갖는 스텐트 | |
US6602283B2 (en) | Stent design | |
JP5042417B2 (ja) | 長さ方向の可撓性と半径方向の剛性を増強した低プロフィール放射線不透過性ステント | |
JP2016501071A (ja) | ハイブリッドパターンを有するステントおよび製造方法 | |
JP4842591B2 (ja) | ステント | |
JP5573911B2 (ja) | 生体留置用ステント | |
JP3663192B2 (ja) | ステント | |
JP4152704B2 (ja) | ステント | |
JP4197918B2 (ja) | ステント | |
JP2003019208A (ja) | ステント | |
JP2002360707A (ja) | ステント | |
JP2009125219A (ja) | ステント | |
JP2001187149A (ja) | ステント用多層クラッド管及びステント | |
JP4808331B2 (ja) | ステント | |
JP2003102848A (ja) | ステント | |
JP2003190295A (ja) | ステント |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001921925 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001921925 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10257407 Country of ref document: US |